01 2Aspen Pharmacare Holdings
02 2Strides Pharma Science
03 1Adcock Ingram
04 4Aurobindo Pharma Limited
05 1Austell Laboratories
06 3Cipla
07 2Cipla Medpro Manufacturing (Pty) Ltd
08 9Cipla Medpro South Africa
09 6Emcure Pharmaceuticals
10 2GSK
11 11Hetero Drugs
12 1Kiara Health
13 2Laurus Generics
14 2Laurus Labs
15 8Macleods Pharmaceuticals Limited
16 1Micro Labs Limited
17 2Novagen Pharma
18 1Orbit Lifescience
19 1Pfizer Inc
20 1Shanghai Desano Bio-Pharmaceutical
21 4Sun Pharmaceutical Industries Limited
22 14Viatris
23 24ViiV Healthcare
24 1Xixia Pharmaceuticals (Pty) Ltd
01 2Antic-calc Tablet, Film Coated
02 1DSP
03 1Dolutegravir 50Mg 30 Joined' Oral Use
04 1Dolutegravir+Abacavir+Lamivudine 50+600+300Mg 30 Joined' Oral Use
05 1FCR
06 43FCT
07 1FILM COATED PILL
08 2FILM;ORAL
09 4Filmtabl
10 1Filmtablet
11 3ODT
12 11TAB
13 5TABLET
14 1TABLET FOR SUSPENSION
15 2TABLET, FOR SUSPENSION;ORAL
16 3TABLET; ORAL
17 1TABLET; ORAL SUSPENSION
18 19TABLET;ORAL
19 2Tablet
20 1tablet
01 2DISCN
02 49Generic
03 10Originator
04 5Prescription
05 6RX
06 33Blank
01 1ACRIPTEGA
02 2Aedatri
03 1Altaeda
04 1Cagol
05 2DOLUTEGRAVIR
06 1DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
07 10DOLUTEGRAVIR SODIUM
08 1DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE
09 2DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
10 1DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
11 3DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
12 2DOVATO
13 1DTV 50
14 1Daliduo
15 1Dalimune
16 1Damicava
17 1Damicava Paed
18 1Divtrida
19 1Dolutegravir Mylan
20 1Dotenal
21 2Dovato
22 2Dovimil
23 1Envuteg
24 1Gradovir
25 2HETVIR 50
26 2JULUCA
27 1Juluca
28 1Kavideza
29 1Kavmyl
30 1Komycitaf
31 1Kovatrax Tablets
32 2Lanograv
33 1Lavem
34 1Lendofil
35 1Lomida
36 3Luvigen
37 2Milutin
38 1Mylataf
39 1Myltega
40 1Novalute
41 1Nuvaco
42 1OLEGRA
43 2Odinsti Dispersible Tablets
44 1Odystra
45 1RANEGA
46 2Reydin
47 1Stigra
48 1Syromak 10 ODT
49 5TIVICAY
50 1TIVICAY PD
51 2TRIUMEQ
52 1TRIUMEQ PD
53 1Tegem
54 1Telatri
55 1Temiv
56 1Tetrilune
57 5Tivicay
58 1Tivicay 50mg
59 1Tladeez
60 1Tolevtri
61 1Trelavue
62 3Triumeq
63 1VIDOTEG
64 1VOLUTRIP
65 2VUTERAR
66 1Viraten
67 1Vulante
68 1Blank
01 1Australia
02 5Canada
03 2India
04 2Italy
05 2Norway
06 59South Africa
07 1Sweden
08 5Switzerland
09 28USA
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Gradovir
Dosage Form : TAB
Dosage Strength : 50mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Vulante
Dosage Form : FCT
Dosage Strength : 50mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Lendofil
Dosage Form : FCT
Dosage Strength : 50mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 208355
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209658
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 210812
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
Brand Name : DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
Dosage Form : TABLET
Dosage Strength : EQ 50MG BASE; 300MG; 25MG
Packaging :
Approval Date :
Application Number : 212527
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Brand Name : DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG/300MG/300MG
Packaging :
Approval Date :
Application Number : 211868
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR
Dosage Form : FILM;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 215319
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR
Dosage Form : FILM;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 215319
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Brand Name : DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG; 300MG;300MG
Packaging :
Approval Date :
Application Number : 210787
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET; ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 210963
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Brand Name : DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG/300MG/300MG
Packaging :
Approval Date :
Application Number : 210796
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date :
Application Number : 214397
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date :
Application Number : 214397
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date :
Application Number : 214397
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET; ORAL SUSPENSION
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 214566
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 212179
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Brand Name : DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form : TABLET; ORAL
Dosage Strength : 50MG/300MG/300MG
Packaging :
Approval Date :
Application Number : 212303
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Brand Name : DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG; 300MG; 300MG
Packaging :
Approval Date :
Application Number : 213556
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DOLUTEGRAVIR SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209602
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Brand Name : DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG;300MG;300MG
Packaging :
Approval Date :
Application Number : 209670
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TIVICAY
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2013-08-12
Application Number : 204790
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TIVICAY
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2016-06-09
Application Number : 204790
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TIVICAY
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2016-06-09
Application Number : 204790
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
Brand Name : TRIUMEQ
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 600MG BASE;EQ 50MG BASE;300MG
Packaging :
Approval Date : 2014-08-22
Application Number : 205551
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
Brand Name : JULUCA
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE;EQ 25MG BASE
Packaging :
Approval Date : 2017-11-21
Application Number : 210192
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DOLUTEGRAVIR SODIUM; LAMIVUDINE
Brand Name : DOVATO
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE;300MG
Packaging :
Approval Date : 2019-04-08
Application Number : 211994
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TIVICAY PD
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2020-06-12
Application Number : 213983
Regulatory Info : RX
Registration Country : USA
